Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 2/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.58 |
| ▸ | MEN1 | O00255 | 5/20 | 0.53 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.50 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.50 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13391012 | 0.87 | LMNA (0.66) | RAB9AKMT2AMEN1LMNAALDH1A1 | |
| SCHEMBL9621679 | 0.78 | RAB9A (1.00) | RAB9AKMT2AMEN1CSNK2A2CSNK2B | |
| SCHEMBL21382353 | 0.75 | RAB9A (0.64) | RAB9AKMT2AMEN1CSNK2A2CSNK2B | |
| SCHEMBL3932557 | 0.74 | RAB9A (0.62) | RAB9AKMT2AMEN1CSNK2A2CSNK2B | |
| SCHEMBL8934604 | 0.74 | RAB9A (0.62) | RAB9AKMT2AMEN1CSNK2A2CSNK2B | |
| SCHEMBL9845155 | 0.74 | RAB9A (0.62) | RAB9AKMT2AMEN1CSNK2A2CSNK2B | |
| SCHEMBL3932546 | 0.74 | RAB9A (0.62) | RAB9AKMT2AMEN1CSNK2A2CSNK2B | |
| SCHEMBL4875352 | 0.74 | RAB9A (0.62) | RAB9AKMT2AMEN1CSNK2A2CSNK2B | |
| SCHEMBL3891683 | 0.74 | KMT2A (1.00) | KMT2AMEN1LMNAALDH1A1KDM4E | |
| SCHEMBL9845157 | 0.73 | RAB9A (0.61) | RAB9AKMT2AMEN1CSNK2A2CSNK2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100093747-A1 | METHOD OF INDUCING NEGATIVE CHEMOTAXIS | CELTAXSYS, INC. | 2010-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100093747-A1 | METHOD OF INDUCING NEGATIVE CHEMOTAXIS | PMAIP1, CDC42, DCX | RAB9A 826/4885KMT2A 4738/4885MEN1 4129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.